Cell & Gene Exchange, May 2017: Calimmune, Inc.

June 16, 2017
Calimmune is accelerating the promise of stem cell gene therapy to liberate patients from chronic and currently incurable diseases. Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, PhD (California Institute of Technology), Irvin Chen, PhD (University of California, Los Angeles) and Inder M. Verma, PhD (Salk Institute for Biological Studies). It has since advanced lead development programs with novel outpatient gene therapies for hematologic diseases and is privileged to have some of the world’s most respected gene therapy developers, clinicians, scientific advisors and commercialization experts committed to its mission. Speaker: Louis Breton – Co-Founder and CEO
Previous Video
Cell & Gene Exchange, May 2017: ORIG3N
Cell & Gene Exchange, May 2017: ORIG3N

ORIG3N exists at the intersection of biological science and emerging technology. Our research team uses cut...

Next Video
Cell & Gene Exchange, May 2017: Sigilon, Inc
Cell & Gene Exchange, May 2017: Sigilon, Inc

Sigilon is developing curative treatments for chronic diseases using new biomaterials that can shield impla...